Ranbaxy: R1: 215.6, R2: 224, R3: 229, S1: 202.3, S2: 197.2, S3: 188.8
Ranbaxy: USFDA Says:-Won't review drug applications from Ranbaxy's Paonta Sahib Plant. -Ranbaxy facility falsified some drug applications, test data -Still investigating to ensure safety and efficacy of marketed drugs -Asked co to cooperate to resolve queries of data integrity, reliability -Not identified any health risks associated with currently marketed products. Ranbaxy Says:-All Abbreviated New Drug Application (ANDAs) from Paonta Sahib Facility added to list under AIP -Co will continue to cooperate with the US FDA.
Satyam: R1: 46.3, R2: 47.4, R3: 48.7, S1: 43.9, S2: 42.6, S3: 41.5
Satyam Update: -Exclusive: Fujitsu not interested in acquiring a stake in Satyam
-AM Naik says L&T has not given out any offer say Maytas Infra likely to have fired 150 employees. –Sources
RIL: R1: 1280.9, R2: 1295.2, R3: 1304.3, S1: 1257.4, S2: 1248.3, S3: 1234
RIL Sources Say:-Company sends GSPA for KG basin gas to 12 fertiliser companies -Alert: GSPA stands for gas supply and procurement agreement
-Expects GSPA to be signed in the first week of March -GSPA subject to final judgement from Bombay HC -Govt yet to provide names of power companies eligible to receive KG Gas -Gas supply to fertiliser companies expected to commence April first week -Alert: Bombay HC decision on KG Basin gas expected by mid March.
DLF: R1: 160.6, R2: 166.4, R3: 170, S1: 151.1, S2: 147.5, S3: 141.7
DLF on special audit: Says assessment still to be done
Lanco Infra: R1:123.7, R2: 127.1, R3: 129.4, S1: 118.1, S2: 115.8, S3: 112.4
Lanco Infra wins 3,300 MW Bara project in UP: From Katya
SpiceJet: R1: 14.9, R2: 15.4, R3: 15.7, S1: 14.1, S2: 13.7, S3: 13.2
SpiceJet says not looking at US or UK as flying destinations; open to having a strategic alliance with a foreign airline when FDI opens up.
Piramal Health: R1: 186.4, R2: 194.2, R3: 203.4, S1: 169.4, S2: 160.2, S3: 152.4
Sanofi ahead to acquire Piramal Health may pay 50% premium to CMP ((Rs 179))
Ranbaxy: USFDA Says:-Won't review drug applications from Ranbaxy's Paonta Sahib Plant. -Ranbaxy facility falsified some drug applications, test data -Still investigating to ensure safety and efficacy of marketed drugs -Asked co to cooperate to resolve queries of data integrity, reliability -Not identified any health risks associated with currently marketed products. Ranbaxy Says:-All Abbreviated New Drug Application (ANDAs) from Paonta Sahib Facility added to list under AIP -Co will continue to cooperate with the US FDA.
Satyam: R1: 46.3, R2: 47.4, R3: 48.7, S1: 43.9, S2: 42.6, S3: 41.5
Satyam Update: -Exclusive: Fujitsu not interested in acquiring a stake in Satyam
-AM Naik says L&T has not given out any offer say Maytas Infra likely to have fired 150 employees. –Sources
RIL: R1: 1280.9, R2: 1295.2, R3: 1304.3, S1: 1257.4, S2: 1248.3, S3: 1234
RIL Sources Say:-Company sends GSPA for KG basin gas to 12 fertiliser companies -Alert: GSPA stands for gas supply and procurement agreement
-Expects GSPA to be signed in the first week of March -GSPA subject to final judgement from Bombay HC -Govt yet to provide names of power companies eligible to receive KG Gas -Gas supply to fertiliser companies expected to commence April first week -Alert: Bombay HC decision on KG Basin gas expected by mid March.
DLF: R1: 160.6, R2: 166.4, R3: 170, S1: 151.1, S2: 147.5, S3: 141.7
DLF on special audit: Says assessment still to be done
Lanco Infra: R1:123.7, R2: 127.1, R3: 129.4, S1: 118.1, S2: 115.8, S3: 112.4
Lanco Infra wins 3,300 MW Bara project in UP: From Katya
SpiceJet: R1: 14.9, R2: 15.4, R3: 15.7, S1: 14.1, S2: 13.7, S3: 13.2
SpiceJet says not looking at US or UK as flying destinations; open to having a strategic alliance with a foreign airline when FDI opens up.
Piramal Health: R1: 186.4, R2: 194.2, R3: 203.4, S1: 169.4, S2: 160.2, S3: 152.4
Sanofi ahead to acquire Piramal Health may pay 50% premium to CMP ((Rs 179))
No comments:
Post a Comment